国际肿瘤学杂志››2011,Vol. 38››Issue (12): 903-905.
• 综述 •上一篇下一篇
庄珊珊, 方裕森, 陈炯玉
出版日期:
发布日期:
通讯作者:
ZHUANG Shan-Shan, FANG Yu-Sen, CHEN Jiong-Yu
Online:
Published:
Contact:
摘要：研究发现细胞角蛋白19片段抗原21-1（CYFRA21-1）含量在多种恶性肿瘤患者血清中特异性升高。作为一种上皮来源性质的肿瘤标志物，血清CYFRA21-1水平检测对于恶性肿瘤的筛查诊断、疗效评估、复发监测和预后判断具有重要的临床应用意义。
Abstract:Studies demonstrate that the serum levels of cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) are high in various cancer types. As a novel epithelial cells derived tumor marker, detection of the serum level of CYFRA21-1 is of great clinical significance for screening and diagnosis, curative effect evaluation, recurrent monitoring and prognosis assessment for cancer patients.
庄珊珊, 方裕森, 陈炯玉. 血清标志物CYFRA21-1与肿瘤[J]. 国际肿瘤学杂志, 2011, 38(12): 903-905.
ZHUANG Shan-Shan, FANG Yu-Sen, CHEN Jiong-Yu. Sserum markers CYFRA21-1 in cancer[J]. Journal of International Oncology, 2011, 38(12): 903-905.
导出引用管理器EndNote|Reference Manager|ProCite|BibTeX|RefWorks
链接本文:https://gjzlx.sdfmu.edu.cn/CN/
https://gjzlx.sdfmu.edu.cn/CN/Y2011/V38/I12/903
